Obesity is a huge concern for health care and patients. Health care is always looking for ways to help those who have weight problems. A new drug called qsymia to help with weight loss was approved on July 17, 2012. This new diet drug is a combination of two other weight loss medications, phentermine and topirimate.
Qsymia is approved for adult patients who are obese according to their BMI and who have at least one critical condition related to obesity. Three main weight related illnesses to get approval are, high blood pressure, high cholesterol and type 2 diabetes. This medication is to be used in conjunction with a low-calorie diet.
Qsymia increases the risk of birth defects for women in the first trimester of pregnancy. Women who are able to become pregnant will be required to take monthly pregnancy tests while taking this medication. These women will need to take birth control to keep from becoming pregnant while taking the drug.
The FDA approved the new weight-loss medication with a Risk Evaluation and Mitigation Strategy. This is to help keep the public informed about the risks associated with the medication. Patients with glaucoma and hyperthyroidism will not be able to benefit from the new medication.
The most common side effect is constipation, dry mouth and tingling of hands and feet. Other side effects associated with this medication are dizziness, fatigue and a change of taste in food. Patients with a current heart disease or who has had a recent stroke are encouraged not to take this medication. It is recommended to monitor the heart rate while on this medication.
A person taking this medication will need to have an evaluation after 12 weeks of treatment. The evaluation will determine if the patient has had at least a 5 percent weight loss while taking the medication. It will be recommended to discontinue use of this medication for someone who has not had at least a 5 percent weight loss.
This is the second weight-loss drug to be approved by the FDA this year. It has been over a decade since the release of a long-term weight-loss drug. The new drug will be available in the fourth quarter of 2012 and will only be available through certified pharmacies.